ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 60,929 | 52,061 | 48,625 | 54,521 | 57,252 |
| Cost of Goods | 33,898 | 24,413 | 22,314 | 19,985 | 24,540 |
| Gross Profit | 27,031 | 27,648 | 26,311 | 34,536 | 32,712 |
| Operating Expenses | 51,652 | 31,623 | 42,178 | 32,476 | 32,921 |
| Operating Income | -23,723 | -3,562 | -15,553 | 3,045 | 331 |
| Interest Expense | 4,440 | 2,497 | 2,531 | 2,454 | 2,554 |
| Other Income | -2,690 | -1,071 | -67 | -515 | -159 |
| Pre-tax Income | -30,853 | -7,130 | -18,151 | 76 | -2,382 |
| Income Tax | -6,717 | -2,683 | -4,045 | -10 | 1,253 |
| Net Income Continuous | -24,136 | -4,447 | -14,106 | 86 | -3,635 |
| Net Income | $-24,136 | $-4,447 | $-14,106 | $86 | $-3,635 |
| EPS Basic Total Ops | -1.87 | -0.37 | -1.17 | 0.01 | -0.30 |
| EPS Basic Continuous Ops | -1.85 | -0.37 | -1.17 | 0.01 | -0.30 |
| EPS Diluted Total Ops | -1.87 | -0.37 | -1.17 | 0.01 | -0.30 |
| EPS Diluted Continuous Ops | -1.85 | -0.37 | -1.17 | 0.01 | -0.30 |
| EBITDA(a) | $-10,039 | $7,784 | $-4,229 | $13,943 | $11,230 |